Immediate access rheumatology clinic: efficiency and outcomes

Current rheumatology care often involves long waiting times, which can delay diagnosis and treatment. Prior research has shown that early assessment is linked to better outcomes in inflammatory arthritis. However, the effectiveness of immediate access clinics in reducing diagnostic delays and improving patient pain remains unclear. No prior work had resolved how such clinics impact both diagnostic accuracy and long-term patient outcomes. This gap motivated the establishment of an immediate access clinic to evaluate its impact on diagnostic efficiency and patient care. The study aimed to address whether rapid assessment could maintain accuracy while reducing waiting times. It also sought to determine if patients assessed in the clinic experienced better outcomes than those seen elsewhere. The study focused on whether early access could lead to better pain management and diagnostic certainty. These questions remain unanswered in the broader rheumatology literature.

The study aimed to assess the effectiveness of an immediate access clinic in reducing waiting times and improving diagnostic accuracy for rheumatological conditions. The specific problem addressed was the delay in specialist assessment for patients with suspected arthritis. The motivation stemmed from the need to improve early diagnosis and treatment initiation. The researchers wanted to determine if rapid assessment could maintain diagnostic precision while shortening wait times. They also sought to compare outcomes between patients assessed in the clinic versus those followed elsewhere. The study focused on whether early access could lead to better pain management and diagnostic certainty. The goal was to evaluate the clinic's role in improving patient outcomes and diagnostic accuracy. The findings could inform the design of similar clinics in other settings.

The study evaluated an immediate access clinic (IAC) for rheumatology assessment. Patients were assessed at presentation and followed up after 6 to 12 months. Data were collected on diagnostic accuracy, pain levels, and care outcomes. The IAC was operational from February to December 2009. A total of 1036 patients were assessed during this period. Of these, 660 were available for follow-up assessments. The researchers analyzed whether initial diagnoses were confirmed at follow-up. They also compared pain levels between patients seen in the clinic and those followed elsewhere. The study used a combination of in-clinic and telephone follow-ups to track outcomes.

The IAC assessed 1036 patients, with 223 having symptoms for three months or less. Over 75% of patients suspected of having rheumatoid arthritis (RA), spondylarthropathy, or osteoarthritis had their initial diagnoses confirmed. Men with spondylarthropathy had longer symptom duration than women (54.0 vs 24.0 months; p=0.0082). No gender difference in pain levels was observed. At follow-up, RA patients in the clinic had a median pain reduction of 37.5 mm (10.5-50.5) on the visual analogue scale. In contrast, RA patients followed elsewhere had a 6 mm improvement (p=0.0083). The IAC reduced waiting times for rheumatology assessment. A significant portion of patients were seen before three months of symptom duration.

The IAC significantly reduced waiting times for rheumatology assessment. The clinic achieved a high rate of diagnostic accuracy for inflammatory rheumatic conditions. Patients with RA assessed in the clinic had greater pain reduction at follow-up than those treated elsewhere. The study found no significant gender differences in pain levels. Men with spondylarthropathy had longer symptom duration than women. The IAC allowed early assessment for a substantial minority of patients. The authors propose that immediate access clinics can improve diagnostic efficiency and patient outcomes. These findings suggest that rapid assessment may enhance care for rheumatological conditions.